骨标记蛋白在基线和胰岛素诱导的低血糖后在2型糖尿病
Benjamin M L Atkin1, Thozhukat Sathyapalan2, Laura Dempsey3
1Edinburgh Royal Infirmary, Old Dalkeith Road, Edinburgh EH16 4SA, UK.
International journal of molecular sciences
|December 11, 2025
概括
2型糖尿病 (T2D) 患者表现出骨标记蛋白质的改变,甲素和Dickkopf相关蛋白1 (DKK1) 的升高. 低血糖进一步影响骨代谢,这表明T2D,低血糖和骨折风险之间存在联系.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 骨生物学 骨生物学 骨生物学
背景情况:
- 2型糖尿病 (T2D) 矛盾地与更高的骨矿物密度 (BMD) 相关,但骨折率增加.
- 二型糖尿病的低血糖会直接影响骨健康,不仅仅是跌倒,影响细胞代谢.
- 了解低血糖期间T2D中的骨标记蛋白 (BMP) 变化对于骨折风险评估至关重要.
研究的目的:
- 在T2D患者中研究循环骨标记蛋白 (BMPs),与健康对照对比.
- 分析诱导低血糖对T2D和对照组BMP的影响.
- 探索将T2D,低血糖和改变的骨代谢联系在一起的潜在机制.
主要方法:
- 涉及T2D患者 (n=23) 和健康对照组 (n=23) 的前性探索性并行研究.
- 在基线,低血糖期间和低血糖后,SOMAscan对血液样本进行蛋白质组分析.
- 未调整的重复测量数据分析的线性混合建模.
主要成果:
- 基线差异:在T2D中增加了Dickkopf相关蛋白1 (DKK1) 和cathepsins (A,S,Z),纤维细胞生长因子23 (FGF23) 较低.
- 低血糖引起了多种BMP的短暂变化,包括DKK1,甲状腺激素 (PTH),甲状腺前腺激素 (PTH) 和互白素-1β (IL1β).
- 在低血糖症后24小时观察到的显著差异:T2D中甲素S下降,在两组中甲素Z增加.
结论:
- 在T2D中甲素和DKK1的基线升高可能会促进骨质再吸收和抑制骨质形成,可能会损害骨质量.
- 低血糖引起的骨标记物,特别是甲素S和Z的变化表明,在急性事件之外,对骨生理学的长期影响.
- 这些发现突出了T2D中骨折风险增加的潜在机制,受代谢状态和低血糖发作影响.
相关概念视频
Hypoglycemia and Glucagon
772
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
772
Hormones Regulating Blood Glucose
6.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.3K
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Dipeptidyl Peptidase 4 Inhibitors
557
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
557
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K


